The practice of medicine is undergoing radical transformation

Hello Tomorrow
Nov 10, 2016 · 3 min read

SPEAKER PREVIEW

  • Aubrey de Grey, Biomedical Gerontologist & Chief Science Officer — SENS Research Foundation. The SENS Research Foundation, is a California-based biomedical research charity that performs and funds laboratory research dedicated to combating the aging process.
  • Andrew May, Chief Scientific Officer — Caribou Biosciences. He has a background developing technologies and bringing innovative products from concept to commercialization. He is a co-founder of Intellia Therapeutics and before joining Caribou, Andy led development teams in sequencing, single-cell genomics and structural proteomics at Fluidigm Corporation.
  • Henry T. Greely, Director, Center for Law and the Biosciences — Stanford University. He is also Professor (by courtesy) of Genetics, Stanford School of Medicine; Chair, Steering Committee of the Center for Biomedical Ethics; and Director, Stanford Program in Neuroscience and Society. Henry T. Greely (BA ’74) specializes in the ethical, legal, and social implications of new biomedical technologies, particularly those related to neuroscience, genetics, or stem cell research.

THANK YOU TO OUR MAIN GLOBAL & LOCAL PARTNERS

BNP PARIBAS & BANK OF THE WEST, Wilson Sonsini Goodrich & Rosati and La French Tech.

Hello Tomorrow Stories

Unlocking the power of deep technologies to solve some of the world’s most pressing issues. We are a nonprofit initiative run by science entrepreneurs, for science entrepreneurs. Find out more at www.hello-tomorrow.org

Hello Tomorrow

Written by

Unlocking the power of deep technologies to solve some of the world's toughest challenges. www.hello-tomorrow.org

Hello Tomorrow Stories

Unlocking the power of deep technologies to solve some of the world’s most pressing issues. We are a nonprofit initiative run by science entrepreneurs, for science entrepreneurs. Find out more at www.hello-tomorrow.org